These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Combined Stereotactic Body Radiotherapy and Checkpoint Inhibition in Unresectable Hepatocellular Carcinoma: A Potential Synergistic Treatment Strategy. Chiang CL; Chan ACY; Chiu KWH; Kong FS Front Oncol; 2019; 9():1157. PubMed ID: 31799176 [No Abstract] [Full Text] [Related]
24. Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma. Wahl DR; Stenmark MH; Tao Y; Pollom EL; Caoili EM; Lawrence TS; Schipper MJ; Feng M J Clin Oncol; 2016 Feb; 34(5):452-9. PubMed ID: 26628466 [TBL] [Abstract][Full Text] [Related]
25. Health economic evaluation of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma: a systematic review. Wang H; Jin C; Fang L; Sun H; Cheng W; Hu S Cost Eff Resour Alloc; 2020; 18():1. PubMed ID: 31938024 [TBL] [Abstract][Full Text] [Related]
27. Stereotactic Body Radiotherapy - Current Indications. Burkoň P; Slavik M; Kazda T; Pospíšil P; Prochazka T; Vrzal M; Šlampa P Klin Onkol; 2019; 32(1):10-24. PubMed ID: 30894002 [TBL] [Abstract][Full Text] [Related]
28. Stereotactic body radiation therapy in primary hepatocellular carcinoma: current status and future directions. Lin TA; Lin JS; Wagner T; Pham N J Gastrointest Oncol; 2018 Oct; 9(5):858-870. PubMed ID: 30505586 [TBL] [Abstract][Full Text] [Related]
29. External beam radiation therapy for hepatocellular carcinoma: potential of intensity-modulated and image-guided radiation therapy. Fuss M; Salter BJ; Herman TS; Thomas CR Gastroenterology; 2004 Nov; 127(5 Suppl 1):S206-17. PubMed ID: 15508086 [TBL] [Abstract][Full Text] [Related]
30. Investigation of dosimetric variations of liver radiotherapy using deformable registration of planning CT and cone-beam CT. Huang P; Yu G; Chen J; Ma C; Qin S; Yin Y; Liang Y; Li H; Li D J Appl Clin Med Phys; 2017 Jan; 18(1):66-75. PubMed ID: 28291931 [TBL] [Abstract][Full Text] [Related]
31. Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease. Cheng JC; Wu JK; Huang CM; Liu HS; Huang DY; Tsai SY; Cheng SH; Jian JJ; Huang AT Int J Radiat Oncol Biol Phys; 2003 May; 56(1):229-34. PubMed ID: 12694843 [TBL] [Abstract][Full Text] [Related]
32. Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinoma. Kim N; Kim HJ; Won JY; Kim DY; Han KH; Jung I; Seong J Radiother Oncol; 2019 Feb; 131():81-87. PubMed ID: 30773192 [TBL] [Abstract][Full Text] [Related]
33. State of the ablation nation: a review of ablative therapies for cure in the treatment of hepatocellular carcinoma. Salati U; Barry A; Chou FY; Ma R; Liu DM Future Oncol; 2017 Jul; 13(16):1437-1448. PubMed ID: 28685607 [TBL] [Abstract][Full Text] [Related]
34. Stereotactic body radiation therapy for hepatocellular carcinoma. Dawson LA; Hashem S; Bujold A Am Soc Clin Oncol Educ Book; 2012; ():261-4. PubMed ID: 24451745 [TBL] [Abstract][Full Text] [Related]
35. Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current Trends and Controversies. Schaub SK; Hartvigson PE; Lock MI; Høyer M; Brunner TB; Cardenes HR; Dawson LA; Kim EY; Mayr NA; Lo SS; Apisarnthanarax S Technol Cancer Res Treat; 2018 Jan; 17():1533033818790217. PubMed ID: 30068240 [TBL] [Abstract][Full Text] [Related]
36. [External radiotherapy for hepatocellular carcinoma]. Girard N; Mornex F Cancer Radiother; 2011 Feb; 15(1):49-53. PubMed ID: 21237691 [TBL] [Abstract][Full Text] [Related]
37. [Tolerance and efficacy of conformal radiotherapy for hepatocellular carcinoma in cirrhotic patients. Results of the French RTF1 phase II trial]. Mornex F; Girard N; Merle P; Béziat C; Kubas A; Wautot V; Khodri M; Trepo C Cancer Radiother; 2005 Nov; 9(6-7):470-6. PubMed ID: 16219480 [TBL] [Abstract][Full Text] [Related]
38. Functional image-guided stereotactic body radiation therapy planning for patients with hepatocellular carcinoma. Tsegmed U; Kimura T; Nakashima T; Nakamura Y; Higaki T; Imano N; Doi Y; Kenjo M; Ozawa S; Murakami Y; Awai K; Nagata Y Med Dosim; 2017 Summer; 42(2):97-103. PubMed ID: 28433483 [TBL] [Abstract][Full Text] [Related]
39. How to Improve Therapeutic Ratio in Radiotherapy of HCC. Tsai CL; Hsu FM; Cheng JC Liver Cancer; 2016 Jul; 5(3):210-20. PubMed ID: 27493896 [TBL] [Abstract][Full Text] [Related]